Arecor announces launch of Ogluo® in the Netherlands
Launch builds on continued pan-European commercial roll-out following earlier launches in Denmark, Norway, Austria, Germany and the UK.
Transforming Healthcare Podcast: The importance of collaboration and cooperation in healthcare
In this episode, Dr Bipin Patel reunites with Tony Jones, Chief Executive of One Nucleus, a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge.
From female psychopaths to the future of mental health and dementia treatment: Cambridge Festival reveals latest research
Are there more female psychopaths than we thought? How can a new approach to mental health lead us out of the growing crisis? Could new combinations of repurposed drugs promote ‘brain repair’ in MS? What’s the latest in dementia research and treatment?
SPT Labtech and RevoluGen demonstrate fully automated Bead-Based High Molecular Weight DNA Extraction
The collaboration delivers a walk-away solution suitable for high-throughput long-read sequencing in under two hours.
District Council helps bring lifesaving defibrillators to the community
Lifesaving equipment has been installed in sheltered housing communal rooms across South Cambridgeshire thanks to the District Council securing funding.
Bio-Rad launches Vericheck ddPCR Replication Competent Lentivirus and Replication Competent AAV Kits for cell and gene therapy production
Rapid, Sensitive, and Validated Detection of Viral Replication Genes Using Droplet Digital™ PCR During Cell and Gene Therapy Production
New screening tool to explore mechanisms behind cancer, autoimmunity and neurodegeneration
Scientists have developed a new screening tool to uncover how genetic changes affect gene activity and can lead to diseases such as cancer, autoimmunity, neurodegeneration and cardiovascular disease. This new tool enables the investigation of thousands of DNA mutations identified by genetic studies in one experiment, guiding the development of advanced diagnostics and treatments.
2024 Corazon's Charity of the Year
Corazon Health is delighted to announce that EACH (East Anglia's Children's Hospices) has been chosen as their 2024 Charity of The Year, following a selection process that included a vote by employees.
Optibrium launches a metabolism prediction software platform tailored to DMPK scientists
Semeta™ offers high sensitivity and superior precision for the prediction of Phase I and II metabolic routes, sites, products and liabilities in early drug discovery
Pioneering cataract test for babies has worldwide potential
Researchers are calling on new parents to back a national study to help prevent the most common cause of preventable childhood blindness, congenital cataracts.
CRA Insights: A landscape assessment of newborn screening (NBS) in Europe
Newborn screening (NBS) has become an integral part of many public health programs.1 NBS programs have minimized patient s
Jon Hume joins Cuttsy+Cuttsy as New Commercial Director
Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.
TR Events & Catering Announces George Nolan as New Head of Sales
TR Events & Catering, a leading multi-service event management provider in Cambridgeshire and Suffolk, is thrilled to announce the appointment of George Nolan as the new Head of Sales. This appointment is a significant milestone for the company, signalling its continued growth and evolution in the competitive event management industry.
Crème de la Crème expands services to the USA and beyond
Crème de la Crème, a leading provider of regulatory advice and support to the health and beauty cosmetics industry, is excited to announce its expansion from the European Union and the United Kingdom to the United States and beyond.
Butterfly and moth genomes mostly unchanged despite 250 million years of evolution
Comparison of over 200 high-quality butterfly and moth genomes reveals key insights into their biology, evolution and diversification over the last 250 million years, as well as clues for conservation.
Challenges to a dual: What makes a dual-brand approach viable?
Pharmaceutical and biologic therapies are increasingly demonstrating their effectiveness in the treatment of multiple diseases.
SPT Labtech continues to support UKHSA genomics surveillance project to bolster global health security
Cambridge – SPT Labtech, a global leader in the design, development and manufacture of automated instrumentation and consumables for life science applications, continues its partnership with the UK Health Security Agency (UKHSA) to advanc
Drug trial brings hope to Parkinson’s patients
Cambridge researchers and Addenbrooke’s Hospital patients are joining forces to trial a new drug aimed at treating Parkinson’s disease.
Launching evolue - hello World
Hello World We are excited to announce the official launch of evolue, a dynamic agile consultancy, that is committed to empowering organisations and individuals in navigating the ever-changing landscape of today's world.About Us:
MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space
Company’s synthetic affinity reagents are antibody alternatives designed to advance the speed, safety, and efficiency of manufacturing at scale, making advanced therapies more accessible to patientCMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa
Sushobhan Dasgupta joins as President and Chief Commercial Officer for Asia Pacific, the Middle East and Africa.
New sponsorship rules to impact care providers and overseas care workers
From 11 March 2024, care providers in England will only be able to sponsor new overseas nationals if they are providing services regulated by the Care Quality Commission (CQC), says head of Stone King’s immigration team, Julie Moktadir.
Trust backs study to fight asbestos-related cancer
An Addenbrooke’s consultant clinical oncologist is part of an international team led by Queen Mary University of London to make a significant breakthrough in the treatment of a rare and hard-to-treat cancer.
Key genes linked to DNA damage and human disease uncovered
More than one hundred key genes linked to DNA damage have been uncovered through systematic screening of nearly 1,000 genetically modified mouse lines, in a new study published (14 February) in Nature.
Optibrium enables collaborative design in its StarDrop platform
The new Idea Tracker capability further improves the efficiency of drug discovery by supporting project management, idea sharing and molecule design tracking The software promotes collaboration within and across teams for more cohesive workflows